The provided text consists of a press release from Thermo Fisher Scientific, dated October 22, 2025, detailing their third quarter financial results for the period ending September 27, 2025. The company reported that revenue grew 5% to $11.12 billion and highlighted major achievements, including the FDA approval for the Oncomine Dx Express Test and a new strategic collaboration with OpenAI to advance artificial intelligence applications. The release contains detailed tables of unaudited financial statements, reconciling both GAAP and non-GAAP figures for key metrics like revenue, earnings per share (EPS), and operating income, comparing the 2025 results with those from 2024. Furthermore, the source includes a Safe Harbor Statement and contact information for media and investors regarding the earnings report.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana